Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9812336rdf:typepubmed:Citationlld:pubmed
pubmed-article:9812336lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:9812336lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:9812336lifeskim:mentionsumls-concept:C1519477lld:lifeskim
pubmed-article:9812336lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:9812336lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:9812336lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:9812336lifeskim:mentionsumls-concept:C0061300lld:lifeskim
pubmed-article:9812336pubmed:issue10lld:pubmed
pubmed-article:9812336pubmed:dateCreated1998-12-10lld:pubmed
pubmed-article:9812336pubmed:abstractTextThe inhibitory effect of 15 semi-synthetic analogues of glaucine (1) on the lipopolysaccharide (LPS)-induced and the concanavalin A (Con A)-induced proliferation of mouse splenocytes was compared in vitro. Isoboldine (3), bracteoline (4) and dehydroglaucine (9) showed a significantly higher potency to suppress LPS-induced proliferation than 1, while 7-hydroxy-4-methylglaucine (8), 7-formyldehydroglaucine (11), 7-acetyldehydroglaucine (13), 7-benzoyldehydroglaucine (14), oxoglaucine (15) and glaucine-quinol (16) were less inhibitory. Compounds 3, 4, boldine (5), 15 and 16 surpassed significantly the inhibition expressed by 1 on Con A-induced proliferative response. The effect was equal to the inhibition determined for mitomycin C (Mit C) with both mitogens. In contrast to all others analogues, thaliporphine (2) stimulated splenocyte proliferation in both assays. Antibody response against sheep red blood cells (SRBC) was lowered most strongly by cataline (6), 7-methyldehydroglaucine (10) and 16.lld:pubmed
pubmed-article:9812336pubmed:languageenglld:pubmed
pubmed-article:9812336pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9812336pubmed:citationSubsetIMlld:pubmed
pubmed-article:9812336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9812336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9812336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9812336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9812336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9812336pubmed:statusMEDLINElld:pubmed
pubmed-article:9812336pubmed:monthOctlld:pubmed
pubmed-article:9812336pubmed:issn0031-7144lld:pubmed
pubmed-article:9812336pubmed:authorpubmed-author:PhilippeMMlld:pubmed
pubmed-article:9812336pubmed:authorpubmed-author:NikolovaPPlld:pubmed
pubmed-article:9812336pubmed:authorpubmed-author:IvanovskiVVlld:pubmed
pubmed-article:9812336pubmed:issnTypePrintlld:pubmed
pubmed-article:9812336pubmed:volume53lld:pubmed
pubmed-article:9812336pubmed:ownerNLMlld:pubmed
pubmed-article:9812336pubmed:authorsCompleteYlld:pubmed
pubmed-article:9812336pubmed:pagination694-8lld:pubmed
pubmed-article:9812336pubmed:dateRevised2007-1-29lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:meshHeadingpubmed-meshheading:9812336-...lld:pubmed
pubmed-article:9812336pubmed:year1998lld:pubmed
pubmed-article:9812336pubmed:articleTitleGlaucine analogues as inhibitors of mouse splenocyte activity.lld:pubmed
pubmed-article:9812336pubmed:affiliationInstitute of Organic Chemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria.lld:pubmed
pubmed-article:9812336pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9812336pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:9812336pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed